To The Moon

$Tesla Motors(TSLA)$ 's stock price surged 12% to $162.13 on Wednesday, a day after the company reported its sharpest revenue drop in 12 years, a 55% drop in net profit from a year earlier.All key indicators missed expectations, but they announced a budget car plan! Wall Street analysts had mixed reactions. Here are the latest analyst views and comments on Tesla stock:1.Bank of America: More Positive Catalysts Ahead $Bank of America(BAC)$ analysts upgraded their rating on Tesla from "neutral" to "buy," but maintained a target price of $220. They cited the company's management addressing recent negative catalysts like slowing sales growth, narrowing margins, product launch concerns, layoffs, and high invent

$Bank of America(BAC)$ kept its "buy" rating and $225 target price for $Apple(AAPL)$ shares on Monday, and naming it as the "best pick" for 2024. The bank said that the slowdown in Apple's expected earnings growth has largely been reflected in the stock price, but AI-powered iPhone could drive a 36% surge in its stock price.Wasmi Mohan, an analyst at American Bank, commented:The demand is softer than we'd like, but the 14% decline in Apple's stock price so far this year has already been priced in. At the same time, the forecast for the rest of the year remained relatively unchanged. In fact, we've identified four potential catalysts that could boost the stock price before the year is out.Four CatalystsThe

The Hong Kong stock market after hours yesterday, $New Oriental Education & Technology(EDU)$ announced its fiscal third-quarter results for 2024 (covering the three months ending February 29th this year) , and its share price plummeted by nearly 20% today. What's going on? Did their earnings blow up?In revenue, New Oriental revenue was $1.2 billion in the third quarter, a whopping 60% increase year-over-year.By segments, the number of schools and learning centers hit 911, up 27.9% from the previous year. Revenue from new educational businesses surged 72.7% year-over-year.New Oriental didn't separately disclose the revenue and financial status of $EAST BUY(01797)$ , which doesn't publish quarterly repo

After hours yesterday, chip giant $Texas Instruments(TXN)$ released its first-quarter report, and the results were better than expected, sending its stock price soaring over 7%.Specifically, TI raked in $3.66 billion in revenue for the first quarter, down 16.4% year on year, the largest decline since 2014, but exceeded analysts' expectations of $3.6 billion, at the high end of the management's guidance of $3.45-3.75 billion:The sales slide hit TI's profitability hard. Its gross margin for the quarter was 57.2%, and its net adjusted profit margin was 24.9%, both significantly lower than the same period last year.Behind the numbers, it's all about lackluster demand. TI's products are mainly used in industrial and automotive markets, which combined co

This year, the energy sector in the US stock market has outperformed the $S&P 500(.SPX)$ , and the price of crude oil has been on a tear. The WTI crude oil futures have jumped over 35% in the past three years, fueling a significant increase in free cash flow for US oil stocks. As profits rise, so do stock prices!Here are five US oil stocks that have the highest correlation with $WTI Crude Oil - main 2406(CLmain)$ prices and are also rated as "buy" by Bank of America.1.Targa Resources Corp Analysts predict that $Targa Resources(TRGP)$ will benefit from overbuilding in the Permian Basin's natural gas liquids pipeline system, and the company still expects pr

$Medtronic PLC(MDT)$ is a medical device stock that covers over 150 countries and sells products for over 70 different diseases. It's truly a core holding for healthcare investors. But the stock has been in a slump, with its share price falling 8% over the past five years.Now, investors in Medtronic are faced with a choice: buy, sell, or hold?Can MDT regain its growth?One of the reasons this medical device stock has been languishing is its lackluster growth in recent years. Over the past five years,, Medtronic's average quarterly revenue growth has been less than 2%, which is difficult to attract growth-oriented investors. But Medtronic's future revenue growth can still be expected to accelerate. The company is actively developing innovative new pr

图片$S&P 500(.SPX)$ closed down 62 points, or 1.2%, on Monday, marking its steepest two-day percentage decline in over a year and its largest two-day point decline since late 2022. But market analysts generally believe the US stock market hasn't fallen to the bottom！Recently, the US stock market has been buffeted by two major forces: the Fed's expectations for interest rate cuts and the situation in the Middle East.Nicholas Rabe, co-founder of DataTrek, said:The stock market is now caught between a rock and a hard place. On one hand, there's a robust and inflationary US economy, and on the other, there's a widening conflict in the Middle East that's setting the stage for an economic recession. Plus, the so-called 'fear index' –

图片Pharmaceutical giant $Merck(MRK)$ has acquired startup Abceutics for $208 million, acquiring the company's medical technology payloads in combination with selective enhancers (PBSEs) that have high potential in the field of antibody-drug conjugate(ADC).ADC drugs are currently a hot area of oncology drug development, and many large pharmaceutical companies want to get a piece of the pie, and Merck is no exception.Merck has six ADC drugs in late-stage clinical trials for cancers including small cell lung cancer, non-small cell lung cancer (NSCLC) and endometrial cancer. Mordor Intelligence predicts the global ADC drug market will grow from $12 billion this year to $44 billion in 2029.In the last 12 months, Merck's revenue was just over $60 billion.

图片With the Fed expected to cut rates, high-yield dividend stocks are poised for a major rally. Fund managers are eager to snap up these juicy dividends in a low-rate environment. $AT&T Inc(T)$ , the telecom giant, and $Pfizer(PFE)$ , the drugmaker, seem like steals right now. Both of these stocks offer yields above 6%. Once rates start to drop, fund managers will be all over them like flies on honey!1.AT&T AT&T, a household name in the US telecom industry, is trading at a significant discount. While the industry average trailing PE ratio is 11.7, AT&T's PE ratio stands at just 8.84.This low valuation, coupled with AT&T's impressive 6.4% annualized yield, makes it a potential gem for both

图片The earnings season is coming, and it could be just the catalyst needed to take the US stock market to the next level!This week, companies like $Delta Air Lines(DAL)$ , $Canopy Growth Corporation(CGC)$ , $JPMorgan Chase(JPM)$ , and $Fastenal(FAST)$ are all set to release their first-quarter earnings, and chances are they'll beat analysts' expectations.Chris Senyek, the chief investment strategist at Wolfe Research, said:Over the past four quarters, the S&P 500 has beaten earnings estimates by an average of 7.1%. And since analysts have already trimmed their first-quarter forecasts by 2.5%, it's likely we'll see some p